Cover Image

Examining the root causes of drug shortages : challenges in pharmaceutical drug supply chains : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighteenth Congress, first session, May 11, 2023.

Bibliographic Details
Corporate Author:	United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (Author)
Format:	Government Document eBook
Language:	English
Published:	Washington : U.S. Government Publishing Office, 2024.
Subjects:	United States. > Food and Drug Administration > Rules and practice. Generic drugs > Prices > United States. Prescription pricing > United States. Drugs > United States > Generic substitution. Business logistics. Patent medicines > Law and legislation > United States. Health. Commerce. Legislative hearings.
Online Access:	https://purl.fdlp.gov/GPO/gpo232032

Similar Items

Generic drug user fee amendments : accelerating patient access to generic drugs : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session ... January 28, 2016.
Published: (2018)

Frecuentes preguntas acerca de las drogas genéricas.
Published: (2004)

Why are some generic drugs skyrocketing in price? : hearing before the Subcommittee on Primary Health and Aging of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Thirteenth Congress, second session, on examining the pricing of generic drugs, November 20, 2014.
Published: (2017)

The effect of generic drug competition on generic drug prices during the Hatch-Waxman 180-day exclusivity period /
by: Olson, Luke M., et al.
Published: (2013)

Generic substitution and prescription drug prices : economic effects of state drug product selection laws /
by: Masson, Alison, et al.
Published: (1985)

Trends in brand name and generic prescribed medicine utilization and expenditures, 1999 to 2003 /
by: Stagnitti, Marie N.
Published: (2006)

Prescription drugs : implications of drug labeling and off-label use : statement of Sarah F. Jagger, Director of Health Services Quality and Public Health Issues, Health, Education, and Human Services Division, before the Subcommittee on Human Resources and Intergovernmental Relations, Committee on Government Reform and Oversight, U.S. House of Representatives /
by: Jagger, Sarah F.
Published: (1996)

Generic drugs : saving money at the pharmacy.
Published: (1998)

Authorized generic drugs : short-term effects and long-term impact.
Published: (2011)

How increased competition from generic drugs has affected prices and returns in the pharmaceutical industry.
Published: (1998)

How increased competition from generic drugs has affected prices and returns in the pharmaceutical industry.
Published: (1998)

Drug pricing : poor prescription for consumers and taxpayers? : hearing before the Committee on Governmental Affairs, United States Senate, One Hundred Third Congress, second session, July 27, 1994.
Published: (1995)

Drug pricing : research on savings from generic drug use /
by: Dicken, John E.
Published: (2012)

Expanding the use of generic drugs.
Published: (2010)

Administered Prices. hearings before the United States Senate Committee on the Judiciary, Subcommittee on Antitrust and Monopoly, Eighty-Sixth Congress, second session, on May 10-13, 1960.
Published: (1960)

Increasing generic drug utilization : saving money for patients : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Ninth Congress, first session, May 18, 2005.
Published: (2005)

Increasing generic drug utilization : saving money for patients : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Ninth Congress, first session, May 18, 2005.
Published: (2005)

The marketing of generic drugs : a guide to counter-strategies for the technology intensive pharmaceutical companies /
by: James, Barrie G.
Published: (1981)

FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session.
Published: (1989)

Prescription drugs : price tends for frequently used brand and generic drugs from 2000 through 2004 : report to congressional requesters.
Published: (2005)

Generic drugs : stakeholders views on improving FDA's information on patents : report to congressional committees /
Published: (2023)

FDA's generic drug application policy : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundredth Congress, second session, July 28, 1988.
Published: (1989)

Generic drugs : saving money at the pharmacy /
Published: (1998)

Generic drug entry prior to patent expiration : an FTC study /
Published: (2002)

Guidance for industry : alternate source of the active pharmaceutical ingredient in pending ANDAs.
Published: (2000)

Generic drug laws : a decade of trial, a prescription for progress /
Published: (1986)

Closing the gaps in Hatch-Waxman : assuring greater access to affordable pharmaceuticals : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventh Congress, second session, on examining certain provisions of the 1984 Drug Price Competition and Patent Term Restoration Act, known as the Hatch-Waxman Act, assuring greater access to affordable pharmaceuticals, May 8, 2002.
Published: (2002)

Closing the gaps in Hatch-Waxman : assuring greater access to affordable pharmaceuticals : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventh Congress, second session, on examining certain provisions of the 1984 Drug Price Competition and Patent Term Restoration Act, known as the Hatch-Waxman Act, assuring greater access to affordable pharmaceuticals, May 8, 2002.
Published: (2002)

Competition in the drug industry : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-seventh Congress, first session, March 10, 1981.
Published: (1981)

Entry threats and pricing in the generic drug industry /
by: Wendling, Brett
Published: (2010)

Examining the Senate and House versions of the "Greater Access to Affordable Pharmaceuticals Act" : hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, first session, August 1, 2003.
Published: (2004)

Examining the Senate and House versions of the "Greater Access to Affordable Pharmaceuticals Act" : hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, first session, August 1, 2003.
Published: (2004)

Orange Book Transparency Act of 2019 : report (to accompany H.R. 1503) (including cost estimate of the Congressional Budget Office).
Published: (2019)

Generic drug enforcement : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, on H.R. 2454 ... June 26, 1991.
Published: (1991)

Generic Animal Drug and Patent Term Restoration Act : hearing before the Subcommittee on Courts, Civil Liberties, and the Administration of Justice of the Committee on the Judiciary, House of Representatives, One Hundredth Congress, second session on H.R. 4982 ... September 14, 1988.
Published: (1989)

Quick tips, when getting a prescription.
Published: (2002)

Skyrocketing prescription drug costs : effects on senior citizens : hearing before the Special Committee on Aging, United States Senate, One Hundred Second Congress, second session, Lewiston, ME, April 15, 1992.
Published: (1993)

Competitive problems in the pharmaceutical drug industry : hearing before the Subcommittee on Antitrust, Monopolas printed], and Business Rights of the Committee on the Judiciary, United States Senate, One Hundredth Congress, first session, on the generic drug industry and its concerns with respect to competition from the brand name manufacturers, October 21, 1987.
Published: (1989)

Developments in the prescription drug market : oversight : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fourteenth Congress, second session, February 4, 2016.
Published: (2017)

Generic drug product development : solid oral dosage forms /
Published: (2005)